FilingReader Intelligence
China Meheco subsidiary wins aspirin drug approval
August 25, 2025 at 09:00 AM UTC•By FilingReader AI
Tianfang Pharmaceutical, a wholly-owned subsidiary of China Meheco, announced its Aspirin Enteric-Coated Tablets have passed the generic drug quality and efficacy consistency evaluation.
The drug required 9.36 million yuan in R&D investment. The domestic market for this product reached approximately 2.8 billion yuan in 2024.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
SSE:600056•Shanghai Stock Exchange
News Alerts
Get instant email alerts when China Meheco publishes news
Free account required • Unsubscribe anytime